NCT02178345View on ClinicalTrials.gov

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

June 24, 2014

Primary Completion Date

December 3, 2021

Study Completion Date

December 3, 2021

Conditions
Papillary Thyroid Cancer
Interventions
PROCEDURE

diffusion weighted (DW) MRI

PROCEDURE

dynamic contrast agent (DCE) MRI

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02178345 - Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer | Biotech Hunter | Biotech Hunter